A traditional Chinese medicine composition for treating liver-kidney and cardiovascular and cerebrovascular diseases and a preparation method thereof

Through a specific formulation of traditional Chinese medicine and its preparation process, this invention addresses the complex pathogenesis of liver and kidney deficiency and cardiovascular and cerebrovascular diseases in middle-aged and elderly individuals. It provides a targeted traditional Chinese medicine composition for regulating and stabilizing blood sugar, suitable for people with hyperglycemia and dizziness, significantly improving symptoms and maintaining the stability of active ingredients.

CN122140847APending Publication Date: 2026-06-05罗守训

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
罗守训
Filing Date
2026-04-29
Publication Date
2026-06-05

Smart Images

  • Figure CN122140847A_ABST
    Figure CN122140847A_ABST
Patent Text Reader

Abstract

This invention discloses a traditional Chinese medicine composition and its preparation method for treating liver, kidney, and cardiovascular diseases, relating to the field of traditional Chinese medicine preparations. It is made from the following raw materials in parts by weight: 10-30 parts of Gastrodia elata, 15-40 parts of Salvia miltiorrhiza, 10-25 parts of Panax quinquefolius, 10-30 parts of Panax notoginseng, 5-20 parts of Chrysanthemum morifolium, and 10-15 parts of Gecko. This traditional Chinese medicine composition and its preparation method for treating liver, kidney, and cardiovascular diseases features synergistic innovation in formulation, is suitable for specific populations, and achieves the therapeutic effects of clearing liver heat, promoting blood circulation, nourishing qi and yin, and tonifying the liver and kidneys. The process preserves the active ingredients, is suitable for absorption by middle-aged and elderly individuals, and maximizes the retention of heat-sensitive active ingredients such as gastrodin, total saponins of Panax notoginseng, tanshinone IIA, and total flavonoids of Chrysanthemum morifolium. The dosage form is flexible and adaptable, with a wide range of applications. Both the ultrafine powder and oral liquid preparations avoid irritating components. The application is clearly targeted, with significant differentiated advantages, especially suitable for middle-aged and elderly men around 70 years old and individuals with hyperglycemia and dizziness.
Need to check novelty before this filing date? Find Prior Art